The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-hydroxy-7-((R)-1-hydroxy-2-((1R,2R)-2-isopropylcyclopentylamino)ethyl)benzo[d]thiazol-2(3H)-one ID: ALA3323657
PubChem CID: 118710939
Max Phase: Preclinical
Molecular Formula: C17H24N2O3S
Molecular Weight: 336.46
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)[C@H]1CCC[C@H]1NC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12
Standard InChI: InChI=1S/C17H24N2O3S/c1-9(2)10-4-3-5-12(10)18-8-14(21)11-6-7-13(20)15-16(11)23-17(22)19-15/h6-7,9-10,12,14,18,20-21H,3-5,8H2,1-2H3,(H,19,22)/t10-,12-,14+/m1/s1
Standard InChI Key: PFGBBCQUFOGHGT-QKCSRTOESA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
20.5357 -4.4367 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5345 -5.2563 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2426 -5.6652 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2408 -4.0279 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9494 -4.4331 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9497 -5.2563 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7326 -5.5105 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.2163 -4.8443 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7322 -4.1786 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
21.2383 -3.2107 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9448 -2.8000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5294 -2.8042 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.9424 -1.9828 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.6489 -1.5721 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3975 -1.9032 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.9425 -1.2943 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5318 -0.5878 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7330 -0.7602 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0335 -4.8440 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.2428 -6.4824 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.5696 -2.7021 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9638 -3.2505 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3475 -2.9525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 5 1 0
4 10 1 0
10 11 1 0
10 12 1 1
11 13 1 0
14 13 1 6
14 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 14 1 0
8 19 2 0
3 20 1 0
15 21 1 6
21 22 1 0
21 23 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 336.46Molecular Weight (Monoisotopic): 336.1508AlogP: 2.74#Rotatable Bonds: 5Polar Surface Area: 85.35Molecular Species: BASEHBA: 5HBD: 4#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: 6.98CX Basic pKa: 9.94CX LogP: 1.94CX LogD: 1.84Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.68Np Likeness Score: 0.48
References 1. Arnold N, Beattie D, Bradley M, Brearley A, Brown L, Charlton SJ, Fairhurst RA, Farr D, Fozard J, Fullerton J, Gosling M, Hatto J, Janus D, Jones D, Jordan L, Lewis C, Maas J, McCarthy C, Mercer M, Oakman H, Press N, Profit R, Schuerch F, Sykes D, Taylor RJ, Trifilieff A, Tuffnell A.. (2014) The identification of 7-[(R)-2-((1S,2S)-2-benzyloxycyclopentylamino)-1-hydroxyethyl]-4-hydroxybenzothiazolone as an inhaled long-acting β2-adrenoceptor agonist., 24 (17): [PMID:25065493 ] [10.1016/j.bmcl.2014.06.014 ]